CClinicalTrials.gg
TerminatedNCT02856828Updated Oct 15, 2019Results posted

Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures

An interventional study of DIE in Radiation Exposure, sponsored by Duke University. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-10-15.

Sponsored by Duke University · Not applicable, Interventional, and Other

Why this study was terminated
Closed due to slow enrollment.
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of a novel digital image enhancement (DIE) technology in reducing the radiation exposure to both the patient and surgical staff during standard intramedullary nail placement for treatment of hip fractures. Secondarily, to evaluate whether the image quality and reproducibility of desired images can be improved with use of the DIE technology. Finally, to evaluate whether DIE technology reduces total operative time.

02

Conditions studied

  • Radiation Exposure

Browse trials for

03

In context

Hip Fractures

822 studies on the registry are indexed under Hip Fractures; 160 are open to participants now.

This study's enrollment of 5 is below the median of 90 across 529 interventional studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • closed hip fracture requiring intramedullary nailing

Exclusion criteria

Exclusion Criteria:

  • age \<18 years
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Digital Image Enhancement (DIE) Group

    A novel digital image enhancement technology will be used intraoperatively

    Device: DIE

  • No intervention
    Control Group

    Standard intraoperative imaging will be used intraoperatively

Interventions

  • DeviceDIE

    digital image enhancement

06

What researchers measure

Primary outcomes

  1. Radiation Exposure to Patient During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge

    Time frame: intraoperatively

  2. Radiation Exposure to Surgeon During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge

    Time frame: intraoperatively

  3. Radiation Exposure to Scrub Tech During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge

    Time frame: intraoperatively

Secondary outcomes

  1. Image Quality and Reproducibility of Desired Images

    Measured by questionnaire related to image quality. Quality scale of 1-10, 1 being poor image quality and 10 being excellent image quality.

    Time frame: intraoperatively

  2. Operative Time

    Time frame: intraoperatively

07

Results

Posted Oct 1, 2019
Limitations and caveats
Only two radiation dosimeters were purchased. Therefore, there is no radiation exposure data for the secondary surgeon.

Participant flow

Participant flow — Overall Study
MilestoneDigital Image Enhancement (DIE) GroupControl Group
Started23
Completed23
Not completed00

Outcome measures

PrimaryRadiation Exposure to Patient During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge
Time frame:
intraoperatively
Reported as:
Number · mGy
Radiation Exposure to Patient During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge
mGyDigital Image Enhancement (DIE) GroupControl Group
Participant 15.12NA
Participant 2NA12.9
Participant 39.79NA
Participant 4NA7.93
Participant 5NA15.41
PrimaryRadiation Exposure to Surgeon During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge
Time frame:
intraoperatively
Reported as:
Number · mrem
Radiation Exposure to Surgeon During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge
mremDigital Image Enhancement (DIE) GroupControl Group
Primary Surgeon 10.7NA
Primary Surgeon 2NA1.9
Primary Surgeon 31.6NA
Primary Surgeon 4NA1.2
Primary Surgeon 5NA3.1
PrimaryRadiation Exposure to Scrub Tech During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge
Time frame:
intraoperatively
Reported as:
Number · mrem
Radiation Exposure to Scrub Tech During Intramedullary Nail Placement for Treatment of Hip Fractures as Measured by Dosimeter Badge
mremDigital Image Enhancement (DIE) GroupControl Group
Surgical Technician 10.5NA
Surgical Technician 2NA1.1
Surgical Technician 30.9NA
Surgical Technician 4NA0.9
Surgical Technician 5NA0.1
SecondaryImage Quality and Reproducibility of Desired Images

Measured by questionnaire related to image quality. Quality scale of 1-10, 1 being poor image quality and 10 being excellent image quality.

Time frame:
intraoperatively
Reported as:
Number · Quality Scale of 1-10, 10 being the best
Image Quality and Reproducibility of Desired Images
Quality Scale of 1-10, 10 being the bestImage Quality of the Digital Image Enhancement (DIE) GroupImage Quality of the Control Group
Participant 1 Image9NA
Participant 2 ImageNA8
Participant 3 Image8NA
Participant 4 ImageNA7
Participant 5 ImageNA9
SecondaryOperative Time
Time frame:
intraoperatively
Reported as:
Number · minutes
Operative Time
minutesDigital Image Enhancement (DIE) GroupControl Group
Participant 151NA
Participant 2NA103
Participant 379NA
Participant 4NA80
Participant 5NA125

Adverse events

Collected over During surgery and post-operative time of hospital admission, approximately 2 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Digital Image Enhancement (DIE) Group0/2 (0%)0/2 (0%)0/2 (0%)
Control Group0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Hip fracture patients only, not surgeons

Age, Categorical
Age, Categorical(Participants)Digital Image Enhancement (DIE) GroupControl GroupTotal
<=18 years000
Between 18 and 65 years011
>=65 years224
Sex: Female, Male
Sex: Female, Male(Participants)Digital Image Enhancement (DIE) GroupControl GroupTotal
Female224
Male011
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Digital Image Enhancement (DIE) GroupControl GroupTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Digital Image Enhancement (DIE) GroupControl GroupTotal
United States235
08

Study locations

1 site
  • Duke University
    Durham, North Carolina 27710, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 29, 2016

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02856828
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Aug 5, 2016
Start date
Mar 1, 2017
Primary completion
Feb 6, 2018
Completion
Feb 6, 2018
Results posted
Oct 1, 2019
Last update
Oct 15, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion